COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab

被引：0
|
作者：
Anne H. Cross
Silvia Delgado
Mario Habek
Maria Davydovskaya
Brian J. Ward
Bruce A. C. Cree
Natalia Totolyan
Ratnakar Pingili
Linda Mancione
Xixi Hu
Roseanne Sullivan
Wendy Su
Ronald Zielman
Ayan Das Gupta
Xavier Montalban
Kevin Winthrop
机构：
[1] Washington University,Department of Neurology
[2] University of Miami Miller School of Medicine,Infectious Diseases Division
[3] University Hospital Center Zagreb,UCSF Weill Institute for Neurosciences, Department of Neurology
[4] University of Zagreb,Department of Neurology
[5] School of Medicine,Neuroimmunology, Centre d’Esclerosi Múltiple de Catalunya (Cemcat)
[6] Moscow State Public Healthcare InsCity Clinical Hospital 24,undefined
[7] Research Institute of the McGill University Health Centre,undefined
[8] University of California San Francisco,undefined
[9] First Saint Petersburg State Medical University,undefined
[10] Novartis Pharmaceuticals Corporation,undefined
[11] Novartis Pharma B.V.,undefined
[12] Novartis Healthcare Private Limited,undefined
[13] Hospital Universitari Vall d’Hebron,undefined
[14] School of Public Health at Oregon Health and Science University,undefined
来源：
Neurology and Therapy | 2022年 / 11卷
关键词：
ALITHIOS; Anti-CD20 therapy; B-cell therapy; COVID-19; Ofatumumab; Post-marketing; Relapsing multiple sclerosis; SARS-CoV-2; Vaccination;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：741 / 758
页数：17
相关论文
共 50 条
  • [41] COVID-19 Vaccine Response in People with Multiple Sclerosis
    Tallantyre, Emma C.
    Vickaryous, Nicola
    Anderson, Valerie
    Asardag, Aliye Nazli
    Baker, David
    Bestwick, Jonathan
    Bramhall, Kath
    Chance, Randy
    Evangelou, Nikos
    George, Katila
    Giovannoni, Gavin
    Godkin, Andrew
    Grant, Leanne
    Harding, Katharine E.
    Hibbert, Aimee
    Ingram, Gillian
    Jones, Meleri
    Kang, Angray S.
    Loveless, Samantha
    Moat, Stuart J.
    Robertson, Neil P.
    Schmierer, Klaus
    Scurr, Martin J.
    Shah, Sita Navin
    Simmons, Jessica
    Upcott, Matthew
    Willis, Mark
    Jolles, Stephen
    Dobson, Ruth
    [J]. ANNALS OF NEUROLOGY, 2022, 91 (01) : 89 - 100
  • [42] COVID-19 and multiple sclerosis: a thematic analysis of the unique experiences of people with multiple sclerosis during the COVID-19 pandemic
    Simcock-Davies, A.
    Da Silva, A.
    Craig, E. M.
    Middleton, R. M.
    Nicholas, R.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 686 - 687
  • [43] Safety, immunogenicity, efficacy, and acceptability of COVID-19 vaccination in people with multiple sclerosis: a narrative review
    Capone, Fioravante
    Rossi, Mariagrazia
    Cruciani, Alessandro
    Motolese, Francesco
    Pilato, Fabio
    Di Lazzaro, Vincenzo
    [J]. NEURAL REGENERATION RESEARCH, 2023, 18 (02) : 284 - 288
  • [44] Safety,immunogenicity,efficacy,and acceptability of COVID-19 vaccination in people with multiple sclerosis:a narrative review
    Fioravante Capone
    Mariagrazia Rossi
    Alessandro Cruciani
    Francesco Motolese
    Fabio Pilato
    Vincenzo Di Lazzaro
    [J]. Neural Regeneration Research, 2023, (02) : 284 - 288
  • [45] COVID-19 Experiences and Vaccination in People with Multiple Sclerosis (P1-1.Virtual)
    Brunn, Jenna
    Dunietz, Galit
    Romeo, Andrew
    Braley, Tiffany
    [J]. NEUROLOGY, 2022, 98 (18)
  • [46] COVID-19 humoral and T-cell mediated vaccination responses in people with multiple sclerosis
    Vickaryous, N.
    Rios, F.
    Schalk, L.
    Asardag, A. N.
    George, K.
    Kang, A.
    Baker, D.
    Giovannoni, G.
    Dobson, R.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 680 - 680
  • [47] COVID-19 in cladribine-treated relapsing-remitting multiple sclerosis patients: a monocentric experience
    Preziosa, Paolo
    Rocca, Maria A.
    Nozzolillo, Agostino
    Moiola, Lucia
    Filippi, Massimo
    [J]. JOURNAL OF NEUROLOGY, 2021, 268 (08) : 2697 - 2699
  • [48] COVID-19 in cladribine-treated patients with relapsing-remitting multiple sclerosis: a monocentric experience
    Preziosa, P.
    Rocca, M. A.
    Nozzolillo, A.
    Moiola, L.
    Filippi, M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 54 - 55
  • [49] Design and rationale for an open-label multicenter phase 4 study assessing Immune response to COVID-19 vaccine in patients with relapsing multiple sclerosis treated with ofatumumab
    Chitnis, T.
    Hendin, B.
    Rammohan, K.
    Yeung, S.
    Meng, X.
    Lucassen, E. B.
    Stankiewicz, J.
    Bar-Or, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 645 - 646
  • [50] COVID-19 in cladribine-treated relapsing-remitting multiple sclerosis patients: a monocentric experience
    Paolo Preziosa
    Maria A. Rocca
    Agostino Nozzolillo
    Lucia Moiola
    Massimo Filippi
    [J]. Journal of Neurology, 2021, 268 : 2697 - 2699
12345